Oxford scientists expect some vaccine data on UK mutant virus by next week
- Country:
- United Kingdom
The University of Oxford expects efficacy data on a study of its COVID-19 vaccine against the UK variant of the coronavirus by next week, a representative said on Wednesday at a virtual meeting of a U.S. CDC advisory panel.
"Since the middle of December, that (UK) variant has been dominant and spread so rapidly. And so, we should be able to put together an analysis on efficacy against that probably by next week," said Andrew Pollard, director of the Oxford Vaccine Group and chief investigator of the trials.
Oxford University has developed the vaccine along with AstraZeneca.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
- READ MORE ON:
- AstraZeneca
- U.S.
- The University of Oxford
- Andrew Pollard
ALSO READ
BRIEF-AstraZeneca To Acquire Amolyt Pharma
AstraZeneca bets on next-generation cancer therapy with $2 bln Fusion deal
Health News Roundup: AstraZeneca to cap out-of-pocket inhaler costs in US, following rival Boehringer's move; Kroger to sell specialty pharmacy business to Elevance Health's CarelonRx and more